# OnCo record paper-bcl-2-cll-nat-rev-drug-discov-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-bcl-2-cll-nat-rev-drug-discov-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-bcl-2-cll-nat-rev-drug-discov-2017" ;
  schema:name "From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors"@en ;
  schema:description "Review on BCL-2 in Chronic lymphocytic leukaemia, in Nature Reviews Drug Discovery (2017), one of the most cited Europe PMC records with BCL-2 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-bcl-2-cll-nat-rev-drug-discov-2017/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/nrd.2016.253>, <https://pubmed.ncbi.nlm.nih.gov/28209992/>, <https://europepmc.org/article/MED/28209992> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/nrd.2016.253> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Ashkenazi A, Fairbrother WJ, Leverson JD, et al." ;
  onco:journals <https://onco.cc/journals/nature-reviews-drug-discovery/> .